Rare Diseases Are Not Rare in China: What can be done more for this Special Category of Patients (CEIBS Working Paper, No. 046/2022/MKT/POM, 2022)

Research output: Working paper

161 Downloads (Pure)

Abstract

During the 2022 session of “two meetings”, rare diseases have been cited as one of the focus in healthcare in Prime Minister working report2. It is an important recognition of the severity of the issue and the need to find practical solutions. This article summarizes the situation of drugs against rare diseases in China and the progress already done. Moving forward, it suggests upgrading their positioning in the healthcare strategy in order to solve an important social issue and bring more steam into innovation in pharmaceutical.
Original languageEnglish
Publication statusPublished - Mar 2022

Source

China Europe International Business School (CEIBS)

Keywords

  • healthcare
  • health

Fingerprint

Dive into the research topics of 'Rare Diseases Are Not Rare in China: What can be done more for this Special Category of Patients (CEIBS Working Paper, No. 046/2022/MKT/POM, 2022)'. Together they form a unique fingerprint.

Cite this